Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-098046
Filing Date
2024-08-16
Accepted
2024-08-16 16:05:04
Documents
1
Period of Report
2024-08-15

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3243
  Complete submission text file 0000950170-24-098046.txt   4906
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Issuer) CIK: 0001580063 (see all company filings)

EIN.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address THERAVANCE, INC. 951 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
dEsparbes Eric (Reporting) CIK: 0001622268 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39334 | Film No.: 241216665